Resilient Financial Performance
Reported pro forma adjusted EBIT of EUR 3.4 billion and cash flow from operations of EUR 2.9 billion, despite a 14% year-on-year decline due to a deteriorating scenario.
Debt Reduction
Lowered net debt and leverage well ahead of the original plan, with expectations to further reduce leverage by year-end.
Strategic Investments and Growth
Confirmed EUR 2.9 billion investment by KKR into Enilive for a 25% stake, and sanctioned two biorefineries in South Korea and Malaysia.
Strong Upstream Performance
Upstream contributed EUR 3.2 billion of pro forma EBIT, with production up 2% year-on-year.
Increased Shareholder Returns
Increased 2024 share buyback to EUR 2 billion, reflecting better-than-planned progress in M&A and business performance.